Rubius Therapeutics, Inc. Free Cash Flow 2018-2022 | RUBY
Rubius Therapeutics, Inc. free cash flow from 2018 to 2022. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Rubius Therapeutics, Inc. Annual Free Cash Flow |
| 2022 |
-137.50 |
| 2021 |
-148.77 |
| 2020 |
-133.15 |
| 2019 |
-151.10 |
| 2018 |
-58.34 |
| 2017 |
-24.19 |
| 2016 |
-9.95 |
| Rubius Therapeutics, Inc. Quarterly Free Cash Flow |
| 2022-12-31 |
-137.50 |
| 2022-09-30 |
-122.66 |
| 2022-06-30 |
-85.59 |
| 2022-03-31 |
-49.54 |
| 2021-12-31 |
-148.77 |
| 2021-09-30 |
-110.19 |
| 2021-06-30 |
-75.05 |
| 2021-03-31 |
-39.49 |
| 2020-12-31 |
-133.15 |
| 2020-09-30 |
-101.57 |
| 2020-06-30 |
-72.51 |
| 2020-03-31 |
-42.87 |
| 2019-12-31 |
-151.10 |
| 2019-09-30 |
-108.84 |
| 2019-06-30 |
-70.13 |
| 2019-03-31 |
-27.04 |
| 2018-12-31 |
-58.34 |
| 2018-09-30 |
-50.32 |
| 2018-06-30 |
-22.25 |
| 2018-03-31 |
-11.72 |
| 2017-09-30 |
-14.16 |
| 2017-06-30 |
-8.68 |
